Access to MRD Testing

You are here:

Home
The Basics
Access to MRD Testing

September 24, 2020

Access to MRD Testing

html5 video converter by EasyHtml5Video.com v4.0

Originally published in The CLL Society Tribune MRD Special Edition.

About the author

Brad Hedrick

Related posts

White Blood Cells and Differential for CLLers
March 22, 2021

ASH 2020: Dr. Adrian Wiestner Discusses the Importance of Test Before Treat™ Predictive and Prognostic Testing in Patients with Chronic Lymphocytic Leukemia (CLL)
March 11, 2021

Testing for Measurable (Minimal) Residual Disease (MRD) in CLL (Chronic Lymphocytic Leukemia) Down to One in One Million Cells Just Got Easier
March 1, 2021

CLL Society On Demand Ed Forum: ASH 2020 Comes to You – Session 1: Encouraging Updates on Drugs in Development + the Sad State of Test Before Treat
February 6, 2021

ASH 2020: Dr. William Wierda on minimal residual disease (MRD)-guided discontinuation of ibrutinib + venetoclax in chronic lymphocytic leukemia (CLL)
January 29, 2021

ASH 2020: Dr. Anthony Mato on the Inform CLL (Chronic Lymphocytic Leukemia) Registry Test Before Treat™
January 25, 2021